News
Learn Excel 365 formulas fast! From AutoSum to Intellisense, learn how to work smarter and analyze data with ease. Tips, ...
Claim this complimentary eBook worth $50 for free, before the offer ends on Sep 16.
PMV Pharmaceuticals has reported a 43% response rate in a midphase ovarian cancer trial, putting the biotech on a track it believes will lead to a filing for FDA approval in the first quarter of 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results